Literature DB >> 28079864

Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

G Al-Ghanem1, P Shah2, S Thomas3, L Banfield1, S El Helou1, C Fusch1, A Mukerji1.   

Abstract

OBJECTIVE: Pulmonary hypertension (PH) is a complication of bronchopulmonary dysplasia (BPD) but the true impact of PH in patients with BPD remains unclear. We sought to systematically review and meta-analyze incidence of PH in BPD and compare clinical outcomes of BPD patients with PH to those without PH in preterm infants. STUDY
DESIGN: Medline, Embase, PsychINFO and CINAHL were searched from January 2000 through December 2015. Cohort, case-control and randomized studies were included. Case-reports, case-series and letters to editors and studies with high risk of bias were excluded. Study design, inclusion/exclusion criteria, diagnostic criteria for BPD and PH and outcomes were extracted independently by two co-authors.
RESULTS: The pooled incidence of PH in patients with BPD (any severity) was 17% (95% confidence interval (CI) 12 to 21; 7 studies) and 24% (95% CI 17 to 30; 9 studies) in moderate-severe BPD. Patients with BPD have higher unadjusted odds of developing PH compared to those without BPD (odds ratio (OR) 3.00; 95% CI 1.18 to 7.66; 4 studies). Patients with BPD and PH were at higher odds of mortality (OR 5.29; 95% CI 2.07 to 13.56; 3 studies) compared with BPD without PH, but there was no significant difference in duration of initial hospitalization, duration of supplemental oxygen requirement or need for home oxygen. No studies included in this review reported on long-term pulmonary or neurodevelopmental outcomes.
CONCLUSIONS: PH occurs in one out of 4 to 5 preterm neonates with BPD. Patients with BPD and PH may have higher odds of mortality; however, there is urgent need for high quality studies that control for confounders and provide data on long-term outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 28079864     DOI: 10.1038/jp.2016.250

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  29 in total

1.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

2.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; Joshua I Miller; John P Kinsella; Christopher D Baker; Brenda B Poindexter; David A Ingram; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

3.  Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern?

Authors:  P S Shah; K Sankaran; K Aziz; A C Allen; M Seshia; A Ohlsson; S K Lee
Journal:  J Perinatol       Date:  2011-05-19       Impact factor: 2.521

4.  Intussusceptive-like angiogenesis in human fetal lung xenografts: Link with bronchopulmonary dysplasia-associated microvascular dysangiogenesis?

Authors:  Monique E De Paepe; Sharon Chu; Susan J Hall; Elizabeth McDonnell-Clark; Nicholas E Heger; Christoph Schorl; Quanfu Mao; Kim Boekelheide
Journal:  Exp Lung Res       Date:  2015       Impact factor: 2.459

Review 5.  Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond.

Authors:  Peter M Mourani; Steven H Abman
Journal:  Curr Opin Pediatr       Date:  2013-06       Impact factor: 2.856

6.  Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Hyo Soon An; Eun Jung Bae; Gi Beom Kim; Bo Sang Kwon; Jae Suk Beak; Ee Kyung Kim; Han Suk Kim; Jung-Hwan Choi; Chung Il Noh; Yong Soo Yun
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

7.  CRIB scores as a tool for assessing risk for the development of pulmonary hypertension in extremely preterm infants with bronchopulmonary dysplasia.

Authors:  Christie J Bruno; Meera Meerkov; Christine Capone; Melissa Vega; Nicole Sutton; Mimi Kim; Dan Wang; Mamta Fuloria
Journal:  Am J Perinatol       Date:  2015-05-08       Impact factor: 1.862

8.  Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  J K Trittmann; L D Nelin; E J Zmuda; J M Gastier-Foster; B Chen; C H Backes; J Frick; P Vaynshtok; V J Vieland; M A Klebanoff
Journal:  Acta Paediatr       Date:  2014-07-06       Impact factor: 2.299

9.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

Authors:  Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

10.  Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.

Authors:  Ekta Khemani; Doff B McElhinney; Lawrence Rhein; Olyn Andrade; Ronald V Lacro; Kristin C Thomas; Mary P Mullen
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

View more
  28 in total

1.  Sildenafil Use in Children with Pulmonary Hypertension.

Authors:  Jennifer L Cohen; Shannon N Nees; Gerson A Valencia; Erika B Rosenzweig; Usha S Krishnan
Journal:  J Pediatr       Date:  2018-11-02       Impact factor: 4.406

2.  Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia.

Authors:  Saima Ahmed; Oludare A Odumade; Patrick van Zalm; Kinga K Smolen; Kimino Fujimura; Jan Muntel; Melissa S Rotunno; Abigail B Winston; Judith A Steen; Richard B Parad; Linda J Van Marter; Stella Kourembanas; Hanno Steen
Journal:  Neonatology       Date:  2022-01-24       Impact factor: 4.035

3.  Inhaled Nitric Oxide Use and Outcomes in Critically Ill Children With a History of Prematurity.

Authors:  Aline B Maddux; Peter M Mourani; Russell Banks; Ron W Reeder; Murray M Pollack; Robert A Berg; Kathleen L Meert; Patrick S McQuillen; Andrew R Yates; Daniel A Notterman; John T Berger
Journal:  Respir Care       Date:  2021-10       Impact factor: 2.339

4.  Lung omics signatures in a bronchopulmonary dysplasia and pulmonary hypertension-like murine model.

Authors:  Amrit Kumar Shrestha; Vashisht Y N Gopal; Renuka T Menon; Joseph L Hagan; Shixia Huang; Binoy Shivanna
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-26       Impact factor: 5.464

5.  Extracellular Vesicles Protect the Neonatal Lung from Hyperoxic Injury through the Epigenetic and Transcriptomic Reprogramming of Myeloid Cells.

Authors:  Gareth R Willis; Monica Reis; Ali Hashemi Gheinani; Angeles Fernandez-Gonzalez; Elizabeth S Taglauer; Vincent Yeung; Xianlan Liu; Maria Ericsson; Eric Haas; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Crit Care Med       Date:  2021-12-15       Impact factor: 21.405

6.  Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants.

Authors:  Karan R Kumar; David A Clark; Evan M Kim; Jasmine D Perry; Kaylyn Wright; Sheikisha A Thomas; Elizabeth J Thompson; Rachel G Greenberg; P Brian Smith; Daniel K Benjamin; Matthew M Laughon; Reese H Clark; Christoph P Hornik
Journal:  J Pediatr       Date:  2018-08-29       Impact factor: 6.314

Review 7.  Diagnostic Approach to Pulmonary Hypertension in Premature Neonates.

Authors:  Vasantha H S Kumar
Journal:  Children (Basel)       Date:  2017-08-24

8.  Incidence, risk factors, and outcomes of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Katelyn MacKenzie; Kathy Cunningham; Sumesh Thomas; Tapas Mondal; Salhab El Helou; Prakesh S Shah; Amit Mukerji
Journal:  Paediatr Child Health       Date:  2019-03-10       Impact factor: 2.253

9.  Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants.

Authors:  Hyun Ho Kim; Se In Sung; Mi Sun Yang; Yea Seul Han; Hye Seon Kim; So Yoon Ahn; Ga Won Jeon; Yun Sil Chang; Won Soon Park
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

10.  Risk Factors and Outcomes of Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia: A Meta-Analysis.

Authors:  Ying Chen; Di Zhang; Ying Li; Aixia Yan; Xiaoying Wang; Xiaoming Hu; Hangting Shi; Yue Du; Wenhui Zhang
Journal:  Front Pediatr       Date:  2021-06-25       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.